Development of late amyloid cardiomyopathy following liver transplantation for hereditary Val30Met transthyretin amyloidosis.

We read with great interest the article by Moshe-Lilie et al. describing their single-center experience of utilising TTR gene specific silencing agents on ATTRv patients with disease progression af...